Skip to main content
SpringerLink
Log in
Book cover

Cardiovascular Endocrinology pp 97–118Cite as

Screening for Cardiovascular Disease in Symptomatic and Asymptomatic Patients with Diabetes Mellitus

  • Chapter

  • 714 Accesses

Part of the book series: Contemporary Endocrinology ((COE))

References

The growing incidence of diabetes mellitus and the continuing epidemic of cardiovascular disease associated with this ailment have induced numerous investigators to seek evidence of pre-clinical disease besides trying to diagnose advanced stages of disease. Although many of the techniques used in the general population to diagnose obstructive coronary artery disease have proven of value, it appears that the overall diagnostic accuracy of these methodologies may be lower in diabetic patients. Furthermore, in the presence of normal results the short-term event rate is considerably higher in a diabetic patient than in the general population. In this chapter, we discuss the current evidence surrounding some of the most popular techniques to diagnose coronary artery disease as well as some emerging techniques for detection of subclinical atherosclerosis.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation. 1999;100:1134–1146.

    PubMed  CAS  Google Scholar 

  2. Grundy SM, Benjamin IJ, Burke GL, et al. Diabetes mellitus: A major risk factor for cardiovascular disease: A joint editorial statement by the American Diabetes Association; the National Heart, Lung, and Blood Institute; the Juvenile Diabetes Foundation International; the National Institute of Diabetes and Digestive and Kidney Diseases; and the American Heart Association. Circulation.1999;100:1132–1133.

    Google Scholar 

  3. Diabetes Statistics. National Diabetes Information Clearinghouse. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, NIH publication. 1999: 99–326.

    Google Scholar 

  4. Nesto RW, Peter L. Diabetes mellitus and the cardiovascular system. In: Braunwald E, Zipes DP, Libby P eds. Heart Disease: A Textbook of Cardiovascular Medicine. Saunders Co: Philadelphia. 2001: 2133–2150.

    Google Scholar 

  5. King H, Aubert RE, Herman WH. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–1431.

    Article  PubMed  CAS  Google Scholar 

  6. Venkat Narayan KM, Boyle JP, Thompson TJ, et al. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003;290:1884–1890.

    Article  Google Scholar 

  7. Haffner SM, Stern MP, Hazuda HP, et al. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA. 1990;263:2893–2898.

    Article  PubMed  CAS  Google Scholar 

  8. Miettinen H, Lehto S, Veikko S, et al. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care. 1998;21:69–75.

    Article  PubMed  CAS  Google Scholar 

  9. Norhammar A, Malmberg K, Diderholm E, et al. Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization. J Am Coll Cardiol. 2004;43:585–591.

    Article  PubMed  Google Scholar 

  10. Mehran R, Dangas GD, Kobayashi Y, et al. Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol. 2004;43:1348–1354.

    Article  PubMed  Google Scholar 

  11. The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: The Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 1997:96:1761–1769.

    Google Scholar 

  12. Gu K, Cowie CC, Harris MI. Diabetes and decline in heart disease mortality in US adults. JAMA. 1999;281:1291–1297.

    Article  PubMed  CAS  Google Scholar 

  13. Froelicher VF, Lehmann KG, Thomas R, Goldman S, Morrison D, Edson R, Lavori P, Myers J, Dennis C, Shabetai R, Do D, Froning J. The electrocardiographic exercise test in a population with reduced workup bias: diagnostic performance, computerized interpretation, and multivariable prediction. Veterans Affairs Cooperative Study in Health Services #016 (QUEXTA) Study Group. Quantitative Exercise Testing and Angiography. Ann Int Med. 1998;128:965–974.

    PubMed  CAS  Google Scholar 

  14. Faglia E, Favales F, Calia P, Paleari F, Segalini G, Gamba PL, Rocca A, Musacchio N, Mastropasqua A, Testori G, Rampini P, Moratti F, Braga A, Morabito A. Milan Study on Atherosclerosis and Diabetes (Mi SAD). Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care. 2002;25:2032–2036.

    Article  PubMed  Google Scholar 

  15. Wei M, Gibbons LW, Kampert JB, Nichaman MZ, Blair SN. Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes. Ann Intern Med. 2000;132;605–611.

    Google Scholar 

  16. Cheng YJ, Lauer MS, Earnest CP, Church TS, Kampert JB, Gibbons LW, Blair SN. Heart rate recovery following maximal exercise testing as a predictor of cardiovascular disease and all-cause mortality in men with diabetes. Diabetes Care. 2003;26;2052–2057.

    Article  PubMed  Google Scholar 

  17. Elhendy A, van Domburg RT, Poldermans D, et al. Safety and feasibility of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in diabetic patients unable to perform an exercise stress test. Diabetes Care . 1998;21:1797–1802.

    Article  PubMed  CAS  Google Scholar 

  18. Gaddi O, Tortorella G, Picano E, et al. Diagnostic and prognostic value of vasodilator stress echocardiography in asymptomatic Type 2 diabetic patients with positive exercise thallium scintigraphy: a pilot study. Diabet Med. 1999;16:762–766.

    Article  PubMed  CAS  Google Scholar 

  19. Bigi R, Desideri A, Cortigiani L, et al. Stress echocardiography for risk stratification of diabetic patients with known or suspected coronary artery disease. Diabetes Care. 2001;24:1596–1601.

    Article  PubMed  CAS  Google Scholar 

  20. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography – summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol. 2003;42:954–970.

    Article  PubMed  Google Scholar 

  21. Penfornis A, Zimmermann C, Boumal D, et al. Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing. Diabet Med. 2001;18:900–905.

    Article  PubMed  CAS  Google Scholar 

  22. Hennessy TG, Codd MB, Hennessy MS, et al. Comparison of dobutamine stress echocardiography and treadmill exercise electrocardiography for detection of coronary artery disease. Coron Artery Dis. 1997;8:171–174.

    PubMed  CAS  Google Scholar 

  23. Marwick TH, Case C, Sawada S, et al. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care. 2002;25:1042–1048.

    Article  PubMed  Google Scholar 

  24. Elhendy A, Arruda AM, Mahoney DW, et al. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol. 2001;37:1551–1557.

    Article  PubMed  CAS  Google Scholar 

  25. Sozzi FB, Elhendy A, Roelandt JR, et al. Prognostic value of dobutamine stress echocardiography in patients with diabetes. Diabetes Care. 2003;26(4):1074–1078.

    Article  PubMed  Google Scholar 

  26. D’Andrea A, Severino S, Caso P, et al. Prognostic value of pharmacological stress echocardiography in diabetic patients. Eur J Echocardiogr. 2003;4:202–208.

    Article  PubMed  CAS  Google Scholar 

  27. McCully RB, Roger VL, Mahoney, et al. DW Outcome after abnormal exercise echocardiography for patients with good exercise capacity: prognostic importance of the extent and severity of exercise-related left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1345–1352.

    Article  PubMed  Google Scholar 

  28. Kamalesh M, Matorin R, Sawada S. Prognostic value of a negative stress echocardiographic study in diabetic patients. Am Heart J. 2002;143:163–168.

    Article  PubMed  Google Scholar 

  29. Villanueva FS, Wagner WR, Vannan MA, Narula J. Targeted ultrasound imaging using microbubbles. Cardiology Clinics. 2004;22:283–298, vii.

    Article  PubMed  Google Scholar 

  30. Kang DH, Kang SJ, Song JM, Choi KJ, Hong MK, Song JK, Park SW, Park SJ. Efficacy of myocardial contrast echocardiography in the diagnosis and risk stratification of acute coronary syndrome. Am J Card. 2005;96:1498–1502.

    Article  PubMed  Google Scholar 

  31. Scognamiglio R, Negut C, Ramondo A, Tiengo A, Avogaro A. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2006;47:66–71.

    Article  Google Scholar 

  32. Bates JR, Sawada SG, Segar DS, et al. Evaluation using dobutamine stress echocardiography in patients with insulin-dependent diabetes mellitus before kidney and/or pancreas transplantation. Am J Cardiol. 1996;77:175–179.

    Article  PubMed  CAS  Google Scholar 

  33. Takeuchi M, Miura Y, Toyokawa T, et al. The comparative diagnostic value of dobutamine stress echocardiography and thallium stress tomography for detecting restenosis after coronary angioplasty. J Am Soc Echocardiogr. 1995;5:696–702.

    Google Scholar 

  34. Bigi R, Desideri A, Bax JJ, et al. Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function. Am J Cardiol. 2001;87:283–288.

    Article  PubMed  CAS  Google Scholar 

  35. Picano E, Sicari R, Landi P, et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation. 1998;98:1078–1084.

    PubMed  CAS  Google Scholar 

  36. Klocke FJ, Baird MG, Lorell BG, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation. 2003;108:1404–1418.

    Article  PubMed  Google Scholar 

  37. Cullom SJ. Principles of cardiac SPECT imaging. In: DePuey EG, Garcia EV, Berman DA eds. Cardiac SPECT Imaging. 2nd ed. Lippincott, Williams and Wilkins: Philadelphia, PA. 2001:3–16.

    Google Scholar 

  38. Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36:2138–2147.

    PubMed  CAS  Google Scholar 

  39. Sharir T, Berman DS, Lewin HC, et al. Incremental prognostic value of rest-redistribution (201) Tl single-photon emission computed tomography. Circulation. 1999;100:1964–1970.

    PubMed  CAS  Google Scholar 

  40. Taillefer R, Primeau M, Costi P, Lambert et al. Technetium-99m-sestamibi myocardial perfusion imaging in detection of coronary artery disease: comparison between initial (1-hour) and delayed (3-hour) postexercise images. J Nucl Med. 1991;32:1961–1965.

    PubMed  CAS  Google Scholar 

  41. Taillefer R, Amyot R, Turpin S, et al. Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging. J Nucl Cardiol. 1996;3:204–211.

    Article  PubMed  CAS  Google Scholar 

  42. Calnon DA, Glover DK, Beller GA, et al. Effects of dobutamine stress on myocardial blood flow, 99mTc sestamibi uptake, and systolic wall thickening in the presence of coronary artery stenoses: implications for dobutamine stress testing. Circulation. 1997;96:2353–2360.

    PubMed  CAS  Google Scholar 

  43. Alexander CM, Landsman PB, Teutsch SM. Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart disease. Am J Cardiol. 2000;86:897–902.

    Article  PubMed  CAS  Google Scholar 

  44. Unknown. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Am J Cardiol. 1997;79:134–139.

    Article  Google Scholar 

  45. Koistinen MJ, Huikuri HV, Pirttiaho H, et al. Evaluation of exercise electrocardiography and thallium tomographic imaging in detecting asymptomatic coronary artery disease in diabetic patients. Br Heart J. 1990;63:7–11.

    Article  PubMed  CAS  Google Scholar 

  46. Janand-Delenne B, Savin B, Habib G, et al. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care. 1999;22:1396–400.

    Article  PubMed  CAS  Google Scholar 

  47. May O, Arildsen H, Damsgaard EM, et al. Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based study. Cardiovasc Res. 1997;34:241–247.

    Article  PubMed  CAS  Google Scholar 

  48. Naka M, Hiramatsu K, Aizawa T, et al. Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography. Am Heart J. 1992;123:46–53.

    Article  PubMed  CAS  Google Scholar 

  49. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. BMJ. 1990;301:92–95.

    PubMed  CAS  Google Scholar 

  50. Rutter MK, Wahid ST, McComb JM, Marshall SM. Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. J Am Coll Cardiol. 2002 Jul 3;40(1):56–61.

    Google Scholar 

  51. Senior PA, Welsh RC, McDonald CG, Paty BW, Shapiro AM, Ryan EA. Coronary artery disease is common in nonuremic, asymptomatic type 1 diabetic islet transplant candidates. Diabetes Care. 2005 Apr;28(4):866–72.

    Article  PubMed  Google Scholar 

  52. Cosson E, Paycha F, Paries J, Cattan S, Ramadan A, Meddah D, Attali JR, Valensi P. Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy? Diabet Med. 2004 Apr;21(4):342–348.

    Google Scholar 

  53. Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. 2004;27:1954–1961.

    Article  PubMed  Google Scholar 

  54. American Diabetes Association Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: Miami, Florida. Diabetes Care. 1998; 21:1551–1559.

    Google Scholar 

  55. De Lorenzo A, Lima RS, Siqueira-Filho AG, Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol. 2002;90:827–832.

    Article  PubMed  Google Scholar 

  56. Valensi P, Paries J, Brulport-Cerisier V, Torremocha F, Sachs RN, Vanzetto G, Cosson E, Lormeau B, Attali JR, Marechaud R, Estour B, Halimi S. Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study. Diabetes Care. 2005 Nov;28(11):2722–7.

    Article  PubMed  Google Scholar 

  57. Zellweger MJ, Hachamovitch R, Kang X, Hayes SW, Friedman JD, Germano G, Pfisterer ME, Berman DS. Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients. Eur Heart J. 2004 Apr;25(7):543–550.

    Google Scholar 

  58. Kang X, Berman DS, Lewin H, et al. Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J. 1999;137:949–957.

    Article  PubMed  CAS  Google Scholar 

  59. Kang X, Berman DS, Lewin HC, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J. 1999;138:1025–1032.

    Article  PubMed  CAS  Google Scholar 

  60. Giri S, Shaw LJ, Murthy DR, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation. 2002;105:32–40.

    Article  PubMed  Google Scholar 

  61. Elhendy A, Huurman A, Schinkel AF, Bax JJ, van Domburg RT, Valkema R, Biagini E, Poldermans D. Association of ischemia on stress (99m)Tc-tetrofosmin myocardial perfusion imaging with all-cause mortality in patients with diabetes mellitus. J Nucl Med. 2005 Oct;46(10):1589–1595.

    Google Scholar 

  62. Berman DS, Kang X, Hayes SW, et al. Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men: Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol. 2003;41:1125–1133.

    Article  PubMed  Google Scholar 

  63. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol. 2004;11:171–185.

    Article  PubMed  Google Scholar 

  64. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664–1672.

    Article  PubMed  Google Scholar 

  65. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262–1275.

    PubMed  CAS  Google Scholar 

  66. Stary HC. The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression. Am J Cardiol. 2001;88:16E–19E.

    Article  PubMed  CAS  Google Scholar 

  67. Tintut Y, Demer LL. Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol. 2001;12:555–560.

    Article  PubMed  CAS  Google Scholar 

  68. Watson KE, Demer LL. The atherosclerosis–calcification link? Curr Opin Lipidol. 1996;7:101–104.

    PubMed  CAS  Google Scholar 

  69. Bostrom KI. Cell differentiation in vascular calcification. Z Kardiol. 2000;89:69–74.

    Article  PubMed  CAS  Google Scholar 

  70. Parhami F, Basseri B, Hwang J, Tintut Y, Demer LL. High-density lipoprotein regulates calcification of vascular cells. Circ Res. 2002;91:570–576.

    Article  PubMed  CAS  Google Scholar 

  71. Parhami F, Morrow AD, Balucan J, et al. Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol. 1997;17:680–687.

    PubMed  CAS  Google Scholar 

  72. Tintut Y, Patel J, Parhami F. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the CAMP pathway. Circulation. 2000;102:2636–2642.

    PubMed  CAS  Google Scholar 

  73. Shioi A, Katagi M, Okuno Y, et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res. 2002;91:9–16.

    Article  PubMed  CAS  Google Scholar 

  74. Kizu A, Shioi A, Jono S, et al. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators. J Cell Biochem . 2004 Sep 9 [Epub ahead of print].

    Google Scholar 

  75. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87:E10–E7.

    PubMed  CAS  Google Scholar 

  76. Jono S, Nishizawa Y, Shioi A, Morii H. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation. 1998;98:1302–1306.

    PubMed  CAS  Google Scholar 

  77. Towler DA, Bidder M, Latifi T, et al. Diet-induced diabetes activates an osteogenic gene regulatory program in the aortas of low density lipoprotein receptor-deficient mice. J Biol Chem. 1998;273:27–34.

    Article  Google Scholar 

  78. Mori S, Takemoto M, Yokote K, et al. Hyperglycemia-induced alteration of vascular smooth muscle phenotype. J Diabetes Complications. 2002;16:65–68.

    Article  PubMed  Google Scholar 

  79. Agatston AS, Janowitz AS, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–832.

    Article  PubMed  CAS  Google Scholar 

  80. Rumberger JA, Brundage BH, Rader DJ, et al. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc. 1999;74:243–252.

    Article  PubMed  CAS  Google Scholar 

  81. Bielak LF, Rumberger JA, Sheedy PF 2nd, et al. Probabilistic model for prediction of angiographically defined obstructive coronary artery disease using electron beam computed tomography calcium score strata. Circulation. 2000;102:380–385.

    PubMed  CAS  Google Scholar 

  82. Rumberger JA, Sheedy PF, Breen JF, et al. Electron beam computed tomographic coronary calcium score cutpoints and severity of associated angiographic lumen stenosis. J Am Coll Cardiol. 1997;29:1542–1549.

    Article  PubMed  CAS  Google Scholar 

  83. Budoff MJ, Diamond GA, Raggi P, et al. Continuous probabilistic prediction of angiographically significant coronary artery disease using electron beam tomography. Circulation. 2002;105:1791–1796.

    Article  PubMed  Google Scholar 

  84. Raggi P, Callister TQ, Cooil B, et al. Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography. Circulation. 2000;101:850–855.

    PubMed  CAS  Google Scholar 

  85. Shaw LJ, Raggi P, Schisterman E, et al. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. Radiology. 2003;228: 826–833.

    Article  PubMed  Google Scholar 

  86. Greenland P, LaBree L, Azen SP, et al. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA. 2004;29:210–215.

    Article  Google Scholar 

  87. Wong ND, Sciammarella MG, Polk D, Gallagher A, Miranda-Peats L, Whitcomb B, Hachamovitch R, Friedman JD, Hayes S, Berman DS. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol. 2003 May 7;41(9):1547–1553.

    Article  PubMed  CAS  Google Scholar 

  88. Schurgin S, Rich S, Mazzone T. Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care. 2001;24:335–338.

    Article  PubMed  CAS  Google Scholar 

  89. Mielke CH, Shields JP, Broemeling LD. Coronary artery calcium, coronary artery disease, and diabetes. Diabetes Res Clin Pract. 2001;53:55–61.

    Article  PubMed  CAS  Google Scholar 

  90. Khaleeli E, Peters SR, Bobrowsky K, et al. Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease: Implications for management. Am Heart J. 2001;14:637–644.

    Article  Google Scholar 

  91. Hoff JA, Quinn L, Sevrukov A, et al. The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. J Am Coll Cardiol. 2003;41:1008–1012.

    Article  PubMed  CAS  Google Scholar 

  92. Reaven PD, Sacks J. Investigators for the Veterans Affairs Cooperative Study of Glycemic Control and Complications in Diabetes Mellitus Type 2. Reduced coronary artery and abdominal aortic calcification in Hispanics with type 2 diabetes. Diabetes Care. 2004 May;27(5):1115–1120.

    Article  PubMed  Google Scholar 

  93. Wagenknecht LE, Bowden DW, Carr JJ, Langefeld CD, Freedman BI, Rich SS. Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes. 2001 Apr;50(4):861–866.

    Google Scholar 

  94. Olson JC, Edmundowicz D, Becker DJ, et al. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes. 2000;49:1571–1578.

    Article  PubMed  CAS  Google Scholar 

  95. Dabelea D, Kinney G, Snell-Bergeon JK, et al. The Coronary Artery Calcification in Type 1 Diabetes Study. Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study. Diabetes. 2003;52:2833–2839.

    Article  PubMed  CAS  Google Scholar 

  96. Colhoun HM, Schalkwijk C, Rubens MB, et al. C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification. Diabetes Care. 2002;25:1813–1817.

    Article  PubMed  CAS  Google Scholar 

  97. Hosoi M, Sato T, Yamagami K, et al. Impact of diabetes on coronary stenosis and coronary artery calcification detected by electron-beam computed tomography in symptomatic patients. Diabetes Care. 2002;25:696–701.

    Article  PubMed  Google Scholar 

  98. Wong ND, Rozanski A, Gransar H, Miranda-Peats R, Kang X, Hayes S, Shaw L, Friedman J, Polk D, Berman DS. Metabolic syndrome and diabetes are associated with an increased likelihood of inducible myocardial ischemia among patients with subclinical atherosclerosis. Diabetes Care. 2005;28(6):1445–1450.

    Article  PubMed  Google Scholar 

  99. Anand DV, Lim E, Hopkins D, Corder R, Shaw LJ, Sharp P, Lipkin D, Lahiri A. Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy. Eur Heart J. 2006;27:713–21. [Epub 2006 Feb 23].

    Article  PubMed  Google Scholar 

  100. Qu W, Le TT, Azen SP, et al. Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects. Diabetes Care. 2003;26:905–910.

    Article  PubMed  Google Scholar 

  101. Raggi P, Shaw LJ, Berman DS, et al. Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol. 2004;43:1663–1669.

    Article  PubMed  CAS  Google Scholar 

  102. American Diabetes Association. Standards of medical care in diabetes – 2006. Diabetes Care. 2007;30:S4–S41.

    Google Scholar 

  103. Grundy SM, Garber A, Goldberg R, et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group IV: lifestyle and medical management of risk factors. Circulation. 2002;105:e153–e158.

    Article  PubMed  Google Scholar 

  104. Passa P, Drouin P, Issa-Sayegh M, et al. Coronary disease and diabetes. Diabetes Metab. 1995;21:446–451.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Emory University School of Medicine, Atlanta, GA

    Paolo Raggi & Leslee J. Shaw

Authors
  1. Paolo Raggi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leslee J. Shaw
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Tulane University Health Sciences Center, New Orleans, LO, USA

    Vivian A. Fonseca (MD) (MD)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Raggi, P., Shaw, L.J. (2009). Screening for Cardiovascular Disease in Symptomatic and Asymptomatic Patients with Diabetes Mellitus. In: Fonseca, V.A. (eds) Cardiovascular Endocrinology. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-141-3_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-141-3_7

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-850-8

  • Online ISBN: 978-1-59745-141-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation